Nivaan Care, the Bengaluru-based healthtech company focused on transforming chronic disease management through AI and continuous care, has raised $7 million in a Series A funding round led by Sorin Investments. The round, closed in mid-January 2026, also saw participation from existing investors and new strategic angels with deep expertise in healthcare delivery and digital health scaling. The fresh capital brings Nivaan Care’s total funding raised to more than $10 million since inception.

Nivaan Care’s platform combines remote patient monitoring (via connected devices and wearables), AI-driven risk prediction, personalised care pathways, real-time clinician alerts, and patient engagement tools to manage chronic conditions such as diabetes, hypertension, cardiovascular disease, and obesity. The system analyses continuous data streams glucose levels, blood pressure, activity, diet logs, and medication adherence to detect early deteriorations, trigger timely interventions, and guide patients toward better self-management. Doctors receive prioritised dashboards with actionable insights, enabling proactive rather than reactive care.

Early deployments across partnered clinics and hospitals in Karnataka have shown promising outcomes: 25–40% improvement in medication adherence, significant reductions in HbA1c and blood pressure levels among diabetic and hypertensive patients, and lower rates of emergency visits and hospitalisations. The platform’s AI models are continuously refined with anonymised real-world data, ensuring increasing accuracy and relevance for Indian patient profiles.

Dr. Vikram Singh, Founder & CEO of Nivaan Care, said: “Chronic diseases account for over 60% of deaths in India, yet most care remains episodic and reactive. Our AI platform changes that by enabling continuous, personalised support that keeps patients stable and out of hospitals. This funding allows us to scale rapidly, reach more patients, and prove that tech-enabled chronic care can be both clinically superior and financially sustainable.”

The investment will support several key priorities: expanding the clinician and patient network to multiple states, enhancing AI models for additional chronic conditions (including COPD, thyroid disorders, and kidney disease), integrating with national digital health frameworks like ABDM, and building partnerships with insurers and corporates for preventive health programs. Nivaan Care also plans to deepen its focus on tier-2 and tier-3 cities, where access to consistent specialist care remains limited.

The round reflects growing investor confidence in India’s chronic care space, where rising disease burden, increasing smartphone penetration, and supportive government policies (Ayushman Bharat, National Health Policy) create a fertile environment for scalable, outcome-driven solutions.